Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, reported its financial results for the third quarter ended September 30, 2021, and provided an update on the company’s operations.
November 10, 2021
· 10 min read